UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

Retrovirology, 2018-08, Vol.15 (1), p.56-56, Article 56

2018

Volltextzugriff (PDF)

Emergent drug resistance with integrase strand transfer inhibitor-based regimens

AIDS (London), 2017-06, Vol.31 (10), p.1425-1434

2017

Volltextzugriff (PDF)

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

The Journal of clinical investigation, 2009-03, Vol.119 (3), p.661-673

2009

Volltextzugriff (PDF)

Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase Inhibitors

The Journal of infectious diseases, 2018-10, Vol.218 (11), p.1773-1776

2018

Volltextzugriff (PDF)

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

The Lancet (British edition), 2010-05, Vol.375 (9729), p.1896-1905

2010

Volltextzugriff (PDF)

Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation

Human gene therapy, 2008-10, Vol.19 (10), p.991-999

2008

Volltextzugriff (PDF)

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

Science translational medicine, 2014-08, Vol.6 (250), p.250ra116

2014

Volltextzugriff (PDF)

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis

Open forum infectious diseases, 2019-03, Vol.6 (3), p.ofz060-ofz060

2019

Volltextzugriff (PDF)

Molecular aspects of plant virus transmission by Olpidium and plasmodiophorid vectors

Annual review of phytopathology, 2004-01, Vol.42 (1), p.211-241

2004

Volltextzugriff (PDF)

Nuclear Factor-κB Translocation Mediates Double-Stranded Ribonucleic Acid-Induced NIT-1 β-Cell Apoptosis and Up-Regulates Caspase-12 and Tumor Necrosis Factor Receptor-Associated Ligand (TRAIL)

Endocrinology (Philadelphia), 2003-10, Vol.144 (10), p.4616-4625

2003

Volltextzugriff (PDF)

2′-O-methyl-modified RNAs Act as TLR7 Antagonists

Molecular therapy, 2007-09, Vol.15 (9), p.1663-1669

2007

Volltextzugriff (PDF)

Evidence that Binding of Cucumber Necrosis Virus to Vector Zoospores Involves Recognition of Oligosaccharides

Journal of Virology, 2003-04, Vol.77 (7), p.3922-3928

2003

Volltextzugriff (PDF)

Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2829-2829

2011

Volltextzugriff (PDF)

Pharmacology of a CpG-Linked Anti-Mir-126 Oligonucleotide Targeting Acute Myeloid Leukemia (AML) in Rats and Non-Human Primates (NHP)

Blood, 2023-11, Vol.142 (Supplement 1), p.5754-5754

2023

Volltextzugriff (PDF)

A Phase 1b Study of IDH Inhibition with Enasidenib and MEK Inhibition with Cobimetinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Who Have Co-Occurring IDH2 and RAS Signaling Gene Mutations

Blood, 2022-11, Vol.140 (Supplement 1), p.11761-11762

2022

Volltextzugriff (PDF)

Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Blood, 2022-11, Vol.140 (Supplement 1), p.6235-6236

2022

Volltextzugriff (PDF)

A Phase 1 Study of Venetoclax in Combination with a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed Adults with B-Cell Ph-like ALL

Blood, 2023-11, Vol.142 (Supplement 1), p.2870-2870

2023

Volltextzugriff (PDF)

Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA

The Journal of infectious diseases, 2014-02, Vol.209 (4), p.562-570

2014

Volltextzugriff (PDF)

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

Leukemia & lymphoma, 2024-07, Vol.65 (8), p.1127-1135

2024

Volltextzugriff (PDF)

siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease

The Journal of clinical investigation, 2017-12, Vol.127 (12), p.4437-4448

2017

Volltextzugriff (PDF)

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

Leukemia & lymphoma, 2024-04, p.1

2024

Volltextzugriff (PDF)

ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S276-S276

2021

Volltextzugriff (PDF)

Poster: ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S208-S208

2021

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

KollektionNature Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(72)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(35)
Humans
(21)
Animals
(16)
Biological And Medical Sciences
(12)
Female
(12)
Male
(9)
Mice
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Medical Sciences
(8)
Adult
(6)
Immunology
(5)
Infectious Diseases
(5)
Liquids
(5)
Medicine, Research & Experimental
(5)
Microbiology
(5)
Phenotype
(5)
Research & Experimental Medicine
(5)
Social Sciences
(5)
Virology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

Emergent drug resistance with integrase strand transfer inhibitor-based regimens

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase Inhibitors

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation

Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis

Molecular aspects of plant virus transmission by Olpidium and plasmodiophorid vectors

Nuclear Factor-κB Translocation Mediates Double-Stranded Ribonucleic Acid-Induced NIT-1 β-Cell Apoptosis and Up-Regulates Caspase-12 and Tumor Necrosis Factor Receptor-Associated Ligand (TRAIL)

2′-O-methyl-modified RNAs Act as TLR7 Antagonists

Evidence that Binding of Cucumber Necrosis Virus to Vector Zoospores Involves Recognition of Oligosaccharides

Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1

Pharmacology of a CpG-Linked Anti-Mir-126 Oligonucleotide Targeting Acute Myeloid Leukemia (AML) in Rats and Non-Human Primates (NHP)

A Phase 1b Study of IDH Inhibition with Enasidenib and MEK Inhibition with Cobimetinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Who Have Co-Occurring IDH2 and RAS Signaling Gene Mutations

Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

A Phase 1 Study of Venetoclax in Combination with a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed Adults with B-Cell Ph-like ALL

Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL

siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Poster: ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Aktive Filter

Suchergebnisse filtern